Cargando…

The Negative Prognostic Impact of Lymph Node Skip Metastasis in Stage III Colon Cancer With pN1 Disease: A Single-Center and Retrospective Cohort Study

BACKGROUND: Lymph node skip metastasis is a subgroup of lymph node metastatic patterns with low incidence in node-positive colon cancer. Its clinical significance is still unclear. OBJECTIVE: This study aimed to investigate the prognostic impact of lymph node skip metastasis in stage III colon cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Che-Yuan, Lin, Chun-Chi, Lin, Hung-Hsin, Lan, Yuan-Tzu, Chang, Shih-Ching, Wang, Huann-Sheng, Yang, Shung-Haur, Chen, Wei-Shone, Lin, Jen-Kou, Jiang, Jeng-Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476599/ https://www.ncbi.nlm.nih.gov/pubmed/36538674 http://dx.doi.org/10.1097/DCR.0000000000002383

Ejemplares similares

The Prognostic Role of Para-Aortic Lymph Nodes in Patients with Colorectal Cancer: Is It Regional or Distant Disease?
por: Lu, Hsueh-Ju, et al.
Publicado: (2015)

Risk factors for delayed perineal wound healing and its impact on prolonged hospital stay after abdominoperineal resection
por: Chang, Chu-Cheng, et al.
Publicado: (2019)

Clinicopathological analysis of colorectal carcinoid tumors and patient outcomes
por: Lin, Hung-Hsin, et al.
Publicado: (2014)

Differences in gene mutations according to gender among patients with colorectal cancer
por: Tsai, Yi-Jian, et al.
Publicado: (2018)

Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients
por: Lu, Chieh-Sheng, et al.
Publicado: (2016)

Clinical significance of skip lymph-node metastasis in pN1 gastric-cancer patients after curative surgery
por: Liu, Jin-Yuan, et al.
Publicado: (2019)

Building personalized treatment plans for early-stage colorectal cancer patients
por: Lin, Hung-Hsin, et al.
Publicado: (2017)

Three-dimensional versus conventional two-dimensional laparoscopic colectomy for colon cancer: A 3-year follow-up study
por: Yang, Yi-Wen, et al.
Publicado: (2022)

A Long-Term and Large-Scale Real-World Study in Taiwan: Efficacy of Target Therapy in Stage IV Colorectal Cancer
por: Huang, Sheng-Chieh, et al.
Publicado: (2022)

A comprehensive analysis of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in colorectal cancer
por: Lin, Pei-Ching, et al.
Publicado: (2015)

Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?
por: Tsai, Yi-Jian, et al.
Publicado: (2016)

Patterns of germline and somatic mutations in 16 genes associated with mismatch repair function or containing tandem repeat sequences
por: Chang, Shih‐Ching, et al.
Publicado: (2019)

Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report
por: Lin, Hung-Hsin, et al.
Publicado: (2016)

Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery
por: Yang, Kai-Lin, et al.
Publicado: (2013)

Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients
por: Kuan, Tai-Chuan, et al.
Publicado: (2018)

Molecular and Clinicopathological Differences by Age at the Diagnosis of Colorectal Cancer
por: Chang, Chu-Cheng, et al.
Publicado: (2017)

Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma
por: Lan, Yuan-Tzu, et al.
Publicado: (2021)

Clinicopathological and Molecular Features of Patients with Early and Late Recurrence after Curative Surgery for Colorectal Cancer
por: Lan, Yuan-Tzu, et al.
Publicado: (2021)

The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon
por: Lee, Kun-Han, et al.
Publicado: (2021)

Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)
por: Chang, Shih-Ching, et al.
Publicado: (2020)

Clinical relevance of cell-free DNA in gastrointestinal tract malignancy
por: Lan, Yuan-Tzu, et al.
Publicado: (2016)

Serum CA125 concentration as a predictor of peritoneal dissemination of colorectal cancer in men and women
por: Huang, Chi-Jung, et al.
Publicado: (2016)

Clinical Significance of Lymph Node Micrometastasis in pN0 Gastric Cancer Patients
por: Li, Yu, et al.
Publicado: (2021)

Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan
por: Lee, Yu-Ting, et al.
Publicado: (2015)

Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spread
por: Hsu, Hung-Chih, et al.
Publicado: (2021)

Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy
por: Chen, Kuen-Feng, et al.
Publicado: (2015)

TNM classification: clarification of number of regional lymph nodes for pN0
Publicado: (2001)

Overall Survival of Stage III Colon Cancer with Only One Lymph Node Metastasis Is Independently Predicted by Preoperative Carcinoembryonic Antigen Level and Lymph Node Sampling Status
por: Lin, Been-Ren, et al.
Publicado: (2015)

Examined lymph node count is not associated with prognosis in elderly patients with pN0 thoracic esophageal cancer
por: Zhang, Guoqing, et al.
Publicado: (2021)

Lymph node ratio is inferior to pN-stage in predicting outcome in colon cancer patients with high numbers of analyzed lymph nodes
por: Jakob, Manuel O, et al.
Publicado: (2018)

Positive impact of the negative lymph node count on the survival rate of stage III colon cancer with pN1 and right-side disease
por: Quan, Qi, et al.
Publicado: (2019)

Case Report: A papillary thyroid microcarcinoma patient with skip lymph node metastasis and multiple distant metastasis
por: Jiang, Qin, et al.
Publicado: (2023)

Lymph Node and Bone Marrow Micrometastases Define the Prognosis of Patients with pN0 Esophageal Cancer
por: Karstens, Karl-F., et al.
Publicado: (2020)

Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer Surgery
por: Ahn, Soo Kyung, et al.
Publicado: (2017)

Is Lymph Node Dissection Necessary During Radical Nephroureterectomy for Clinically Node-Negative Upper Tract Urothelial Carcinoma? A Multi-Institutional Study
por: Lee, Hsiang-Ying, et al.
Publicado: (2022)

Predictive Factors for Skip Lymph Node Metastasis and Their Implication on Recurrence in Papillary Thyroid Carcinoma
por: Ryu, Young-Jae, et al.
Publicado: (2022)

Number of negative lymph nodes with a positive impact on survival of stage III colon cancer; a retrospective observation study for right side and left side colon
por: Kuo, Yi-Hung, et al.
Publicado: (2022)

Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer
por: Liu, Chun-Yu, et al.
Publicado: (2021)

Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review
por: Attard, Andrea, et al.
Publicado: (2019)

PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis
por: Dou, Yi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1hagsuhc7j0heiq0rtogh9htlt